;
  • Report:  #1528669

Complaint Review: RxMM Health Ltd - Perth western Australia

Reported By:
Megan - UPPER COOMERA, Queensland, Australia
Submitted:
Updated:

RxMM Health Ltd
45 Ventnor Ave Perth, 6005 western Australia, Australia
Phone:
(08) 9389 4413
Tell us has your experience with this business or person been good? What's this?

Hey Guys, This what we have been getting lately, Just aload of you'll get money soon or more shares are coming your way blah blah . No money has come my way since the investment started  On Mar 5, 2023, at 6:53 AM, Brian Harcourt <[email protected]> wrote:

Dear Shareholder,

 

You may have recently received a scam email from an unknown email address suggesting that RxMM’s  shares in Galexxy Holdings Inc. (GXXY) have been sold and money pocketed by your Directors. The sender of this email obviously has an agenda which is unclear but your Directors categorically deny the insinuations that anything improper has happened with the Company’s selling of Galexxy shares.

 

RxMM has sold Galexxy shares during the last 6 months to fund operations and meet obligations to creditors, and these transactions have been properly accounted for.

 

Re Your Entitlement Shares:  RxMM Shareholders will be receiving a detailed notice confirming, that for every two RxMM shares held, one new Galexxy share will be issued. This distribution totals over 26 million Galexxy shares which are currently held in the register on behalf of all shareholders .

 

As previously advised, the GXXY shares will be distributed to Shareholders following completion of the GXXY audit and the Filing of a FORM-10 with the Securities Exchange Commission. Plans were made to complete this audit and a FORM-10 filing in Q3, 2022, but because GXXY made two acquisitions in August 2022 requiring Consolidation of these two new businesses, an audit for the prior two years is required up to 31 December 2022. This accounting requirement created an unplanned delay and as a result, the 31 December 2022 Audit is now due for completion in May 2023, at which time the GXXY Share Distributions will be made.

 

The unknown email scammer asked shareholders to contact our former communications officer, Rachel Fyffe, at her new employer’s email address which is totally inappropriate.

Rachel has never been an officer or decision maker at RxMM, or any of its subsidiary or associated companies.

 

I am available for any further discussion or questions you may have about the subjects of this email and can be contacted at this email address or on my personal mobile +61 423 555 885.

 

Sincerely        Brian

 

 

 

Brian L. Harcourt

CEO

RxMM Health Ltd

Australia: +61 (0) 423 555 885

USA:         +1 949 456 3326

Skype:   bharcourt

Email:    [email protected]

Web:     www.RxMMhealth.com

 

 

 

Dear Valued Shareholders and Friends,   As the Summer comes to a close so does the $1.50 share price for RxMM Health Capital. We are set to increase RxMM Health Capital to $3.00 per share this Saturday September 1st.   The recent announcement regarding Constellation Brands and their US$4 billion investment in Canopy Growth Corp bodes well for RxMM Health Capital.   The link below shares an interview on CNN Money with Bruce Linton, CEO of Canopy Growth.   https://money.cnn.com/2018/08/15/news/companies/constellation-brands-cannabis-canopy-growth/index.html   Breaking News: U.S. Senate Grants Veterans the Right to Use Medical Marijuana   https://www.potnetwork.com/news/breaking-us-senate-grants-veterans-right-use-medical-marijuana   RxMM Health Capital’s share price increase is partly driven by the following recent developments:

  • Formation of a JV with PFA Energy Solutions to develop the world’s largest (4 M sq. ft.) of pharmaceutical grade cannabis cultivation facility.
  • Near term listing on the CSE, Vancouver asap before year end.
  • Acquisition (pending) of a $4.5m/yr. dispensary including the retail property in Costa Mesa – Includes licenses for cultivation, manufacturing & distribution.
  • Constellations Brands’ recent CA $5 billion + investment in Canopy Growth’s (CGC) shares – CGC’s Market Cap increased to $7B. 

  We've included the RxMM Health Capital Executive Summary and the Share Purchase agreement. The minimum investment in RxMM Health Capital is $25,000. However, if you have a different investment amount in mind, we suggest you share your offer with us and from there, we’ll see if we can accommodate your request.   Please Note: Share Purchase Agreements and subscription funds must be received by end of business day Friday August 31st.   If you have any questions please contact Rachel at: [email protected]. or her mobile: 949-424-4742   All the best,   Ross Lyndon-James

 

 



Reports & Rebuttal
Respond to this report!
Also a victim?
Repair Your Reputation!
//